CAJ | 학술논문

目的：观察静脉化疗联合肝动脉化疗栓塞治疗胃癌伴肝转移的效果。方法：收治胃癌伴肝转移患者80例，随机分成观察组和对照组，各40例。对照组予静脉化疗，观察组在此基础上加肝动脉化疗栓塞治疗，比较两组疗效、中位生存期和不良反应。结果：观察组临床总有效率55.00%高于对照组的37.50%，中位生存期(13.48±2.51)个月多于对照组的(9.73±2.46)个月，差异有统计学意义(P＜0.05)。结论：静脉化疗联合肝动脉化疗栓塞治疗胃癌伴肝转移的效果显著，可延长患者生命且不明显增加不良反应。
목적：관찰정맥화료연합간동맥화료전새치료위암반간전이적효과。방법：수치위암반간전이환자80례，수궤분성관찰조화대조조，각40례。대조조여정맥화료，관찰조재차기출상가간동맥화료전새치료，비교량조료효、중위생존기화불량반응。결과：관찰조림상총유효솔55.00%고우대조조적37.50%，중위생존기(13.48±2.51)개월다우대조조적(9.73±2.46)개월，차이유통계학의의(P＜0.05)。결론：정맥화료연합간동맥화료전새치료위암반간전이적효과현저，가연장환자생명차불명현증가불량반응。
Objective:To explore the effect of intravenous chemotherapy combined with hepatic artery chemoembolization for treatment of gastric cancer with hepatic metastasis.Methods:80 patients with gastric cancer with liver metastasis were selected. They were randomly divided into the observation group and the control group with 40 cases in each group.The control group was given intravenous chemotherapy,and the observation group was given hepatic artery chemoembolization on the basis of the control group.We compared the efficacy,median survival time and adverse reactions of the two groups.Results:In the observation group, the clinical total effective rate of 55% was higher than 37.50% of the control group;the median survival time of (13.48±2.51) month was more than (9.73±2.46)month of the control group;the difference was statistically significant(P<0.05).Conclusion:The effect of intravenous chemotherapy combined with hepatic artery chemotherapy for embolization treatment of gastric cancer with hepatic metastasis is significant.It can prolong the life of patients and there is no significant increase in adverse reactions.